ChemoCentryx

About:

ChemoCentryx is a biopharmaceutical company that develops medications for inflammatory and autoimmune diseases and cancer.

Website: http://www.chemocentryx.com

Twitter/X: chemocentryxinc

Top Investors: Hercules Capital, OrbiMed, Alta Partners, HealthCap, Bio-Techne

Description:

ChemoCentryxis a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer. ChemoCentryx focuses on the discovery, development, and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors. The company's small molecule product candidates are designed to target a specific chemokine or chemo-attractant receptor, thereby blocking the inappropriate immune system cascade underlying a given disease.